See All Slides - tctmd.com

Slides

Presentation TCT 2012

The "Hottest" New Cardiovascular Device Concepts from the Israeli Innovation Pipeline

Presenter: Chaim Lotan

October 22, 2012

Presentation TCT 2012

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

The Globalization of Innovation Is Here to Stay: Reasons, Realities, and Consequences

Presenter: Mitchell Krucoff

October 22, 2012

Presentation TCT 2012

Case 3: LAA Occlusion Case

Presenter: Alexander Osiev

October 22, 2012

Presentation TCT 2012

Evidence/Practice Intersection: LATAM Perspective - Our Routine Daily Approach and Outcomes

Presenter: Jose Mangione

October 22, 2012

Presentation TCT 2012

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

Presenter: Hasan Jilaihawi

October 22, 2012

Presentation TCT 2012

AGA European Registry Results

Presenter: Bernhard Meier

October 22, 2012

Presentation TCT 2012

Current Landscape: One-Year Post-Initial FDA Approval

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

Femoral Vascular Access: Technique, Closure Devices, and Complications

Presenter: Robert Applegate

October 22, 2012

Presentation TCT 2012

Debate: Do the Data Support Endovascular Therapy for Descending Thoracic Aortic Dissections? Con!

Presenter: Christoph Nienaber

October 22, 2012

Advertisement

Slides

The "Hottest" New Cardiovascular Device Concepts from the Israeli Innovation Pipeline

Paravalvular Regurgitation as a Strong Predictor of Post-TAVR Mortality

The Globalization of Innovation Is Here to Stay: Reasons, Realities, and Consequences

Case 3: LAA Occlusion Case

Evidence/Practice Intersection: LATAM Perspective - Our Routine Daily Approach and Outcomes

3-D Annulus Sizing (using MSCT or 3-D Echo) Is Now the Gold Standard and Helps to Reduce Paravalvular Regurgitation After TAVR

AGA European Registry Results

Current Landscape: One-Year Post-Initial FDA Approval

Femoral Vascular Access: Technique, Closure Devices, and Complications

Debate: Do the Data Support Endovascular Therapy for Descending Thoracic Aortic Dissections? Con!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content